These showed a twofold down-regulation of C1ORF112, placing it in the top 30 differentially expressed genes arising between wild‐type presenting TP53 and mutant TP53 cells within invasive bladder tumour cells. The gene discussed is TP53; the disease is urinary bladder neoplasm.